In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pediatrix Medical Group Inc (NYSE: MD) closed the day trading at $14.20 down -1.93% from the previous closing price of $14.48. In other words, the price has decreased by -$1.93 from its previous closing price. On the day, 0.52 million shares were traded. MD stock price reached its highest trading level at $14.54 during the session, while it also had its lowest trading level at $14.19.
Ratios:
For a better understanding of MD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.59. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 0.93 whereas as Long-Term Debt/Eq ratio is at 0.88.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 26, 2024, Upgraded its rating to Buy and sets its target price to $14 from $8 previously.
On June 07, 2024, Deutsche Bank Upgraded its rating to Hold which previously was Sell but kept the price unchanged to $8.
On September 27, 2021, SVB Leerink started tracking the stock assigning a Mkt Perform rating and target price of $29.SVB Leerink initiated its Mkt Perform rating on September 27, 2021, with a $29 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 13 ’24 when ORDAN MARK S sold 27,600 shares for $15.35 per share. The transaction valued at 423,660 led to the insider holds 138,683 shares of the business.
ORDAN MARK S bought 27,600 shares of MD for $427,800 on Nov 13 ’24. On Nov 08 ’24, another insider, Moore Mary Ann E, who serves as the EVP, GC, Chief Admin Off & Sec of the company, sold 8,108 shares for $16.00 each. As a result, the insider received 129,728 and left with 135,810 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 1219502976 and an Enterprise Value of 1663433216. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.61 while its Price-to-Book (P/B) ratio in mrq is 1.66. Its current Enterprise Value per Revenue stands at 0.829 whereas that against EBITDA is 8.357.
Stock Price History:
Over the past 52 weeks, MD has reached a high of $16.41, while it has fallen to a 52-week low of $6.62. The 50-Day Moving Average of the stock is 2.69%, while the 200-Day Moving Average is calculated to be 39.80%.
Shares Statistics:
Over the past 3-months, MD traded about 679.32K shares per day on average, while over the past 10 days, MD traded about 603450 shares per day. A total of 85.87M shares are outstanding, with a floating share count of 84.70M. Insiders hold about 1.38% of the company’s shares, while institutions hold 101.79% stake in the company. Shares short for MD as of 1732838400 were 2982450 with a Short Ratio of 4.39, compared to 1730332800 on 3943253. Therefore, it implies a Short% of Shares Outstanding of 2982450 and a Short% of Float of 4.9000002.
